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Abstract 
While the rapid development of ultrasound elastography techniques in recent decades has 
sparked its prompt implementation in the clinical setting adding new diagnostic information 
to conventional imaging techniques, questions still remain as to its full potential and efficacy 
in the hospital environment. A limited number of technical studies have objectively assessed 
the full capabilities of the different elastography approaches, perhaps due, in part, to the 
scarcity of suitable tissue-mimicking materials and appropriately designed phantoms 
available. Few commercially-available elastography phantoms possess the necessary test 
target characteristics or mechanical properties observed clinically, or indeed reflect the lesion-
to-background elasticity ratio encountered during clinical scanning. Thus, while some 
phantoms may prove useful, they may not fully challenge the capabilities of the different 
elastography technniques, proving limited when it comes to quality control (QC) and/or 
training purposes. Although a variety of elastography tissue-mimicking materials, such as 
agar and gelatine dispersions, co-polymer in oil and poly(vinyl) alcohol cryogel, have been 
developed for specific research purposes, such work has yet to produce appropriately 
designed phantoms to adequately challenge the variety of current commercially-available 
elastography applications. Accordingly, there is a clear need for the further development of 
elastography TMMs and phantoms to keep pace with the rapid developments in elastography 
technology, to ensure the performance of these new diagnostic approaches are validated, and 
for clinical training purposes. 
 
1. Introduction 
For more than two decades, ultrasound elastographic techniques for both measuring and 
imaging the mechanical properties of soft tissues have been of great interest, with the aim of 
these techniques being the presentation of mechanical information of the tissue.1-4 Changes in 
the mechanical properties of tissues are known to correlate closely with various pathological 
conditions and hence ultrasound elastography should provide a method for differentiating 
between various abnormalities and pathological states which may not be apparent using 
traditional ultrasound imaging techniques.5-7 The technology has now reached the stage where 
numerous incarnations have left the research laboratory and are appearing in the clinical 
environment. 
 
Elastographic techniques typically investigate the elastic nature of compliant tissue tracking 
the longitudinal strain of tissue elements by ultrasonically assessing the one-dimensional local 
displacements in the medium.1 Depending on the specific technology and/or clinical 
application, the mechanical information can then be either presented as an average 
measurement across an assumed homogeneous organ (for example, the liver) or, for more 
heterogeneous tissue sections, presented in the form of a parametric map of relative tissue 
property (typically either strain or Young’s modulus 1-4), where a knowledge of normal and 
pathological values can thus provide additional diagnostic possibilities beyond that of 
conventional imaging techniques.5-7  
 
Test objects are widely used in ultrasound imaging. These reproduce the essential geometric 
features of tissue and are acoustically equivalent so that images are comparable with those 
produced clinically. Often, simulated lesions of different sizes are embedded within a tissue-
mimic to enable studies to be performed which are concerned with the detection of minimal 
lesion size. Test objects generally have 3 functions, providing a source of realistic and 
reproducible datasets in the development of new ultrasound techniques, for the objective 
evaluation of the accuracy of particular measurements (eg. lesion size, stenosis diameter), and 
for use in QA/QC programmes. 
 
A concern relating to the clinical implementation of this new technology may be the lack of 
adequate end-user training, which could be significant when one considers that in some cases 
the patient probe can incorporate both a conventional imaging transducer and a device for 
introducing a shear wave into the patient, coupled with the need to obtain accurate and 
sensitive quantitative measurements. Here again, test phantoms have a role to play, ranging 
from simple phantoms designed to allow the user familiarise themselves with the probe and 
how to make a measurement, to more complex phantoms containing various targets designed 
to train users in the identification of tissue pathology in a realistic model using the 
elastographic information content alone or perhaps also in conjunction with B-mode imaging.  
 
The aim of this article is thus to review both the research-based and commercially-available 
test objects which have been developed for both quality control and training purposes, 
covering both their design and composition and their appropriateness for use in various 
clinical situations. The review will begin with a brief description of the technology 
underpinning the main clinically-available ultrasound elastography systems (for a more in-
depth treatise, the reader is referred to the article by Dr. Peter Hoskins in this issue) together 
with a description of the main tissue mimicking materials (TMMs) which have been 
developed for use in the various test phantoms. 
 
2. Elastography techniques  
Four main elastographic approaches have been developed: static elastography, dynamic 
elastography, transient elastography and remote elastography.6,8 Of these four, static, remote 
and transient elastography have been successfully implemented in the clinical environment 
and thus are briefly discussed here. 
 
2.1 Static Elastography 
Static elastography examines the tissue’s response to compression by comparing ultrasonic 
signals of tissue before and after compression.2,9 Static elastography techniques have been 
implemented by a number of manufacturers such as General Electric (USA), Hitachi (Japan), 
Philips (The Netherlands), Siemens (Germany) and Toshiba (Japan), and have become 
commercially available on ultrasound scanners in the clinical areas of breast, prostate and 
thyroid imaging. In most cases, compression to the area of interest is manually applied, with 
some scanners relying on internal patient movement such as respiratory or cardiac motion.10-13 
The commercially-available intravascular ultrasound (IVUS) system (EndoSonics, USA) 
investigates the morphology of the coronary wall and plaque by observing the induced strain 
in the vascular tissue via different levels of the intraluminal pressure.14 While static 
elastography is beneficial for IVUS, the technique is regarded as being limited when applied 
to deep organs such as the liver where predictable and controlled compression is not easily 
attainable due to the organ’s depth.2 Consequently, its use has been limited to the clinical 
areas highlighted above, and test objects should be designed with this in mind. The static 
elastography technique is thus restricted to investigating relative elasticity in small parts 
applications and as such a suitable test object for this technique should contain inserts of 
varying stiffness and sizes relative to the background material, with a range of mechanical 
properties similar to those found in the tissue of interest; see Table 2 for details.  
 
2.2 Remote Elastography 
Acoustic radiation force elastography, also known as remote elastography, utilises an acoustic 
radiation force to generate localised displacements within the tissue by the transfer of 
momentum from the acoustic wave to the propagation medium. This transfer of momentum 
can be used for different elastography approaches, either for strain imaging or for the 
generation of shear-waves for making a quantitative stiffness measure.  
For strain imaging, the mechanical strain within the tissue can be evaluated by measuring 
local tissue displacements, using ultrasonic correlation-based methods.4 This technique, 
effectively a form of static elastography with the compression effected using focussed 
ultrasound, has been implemented clinically by Siemens (Germany) in the form of “Virtual 
TouchTM Tissue Imaging”. Acoustic radiation force impulse imaging (ARFI) of this type has 
been demonstrated to show clinical promise for use with radiofrequency ablation procedures 
of liver lesions.15 An appropriate test phantom for performance assessment of ARFI strain 
imaging, similar to that of static elastography, would contain inserts of varying stiffness and 
sizes embedded in relatively lower background TMM. 
ARFI can also be used to quantity tissue stiffness in a selected region of interest through 
ultrasonically measuring the velocity of shear waves produced by the acoustic radiation 
impulse. This technique has been implemented in the form of Siemen’s “Virtual Touch Tissue 
Quantification” and has been used for the diagnosis of chronic liver disease by correlating 
shear wave velocity with liver fibrosis.16 For ARFI, where the shear wave velocity is 
measured, test phantoms should contain homogenous regions with a range of shear wave 
velocities for assessment of the systems accuracy. The range of mechanical properties for 
ARFI phantoms should be similar to those found in the tissue of interest, see Table 2 for 
details. 
Further applications of ARFI elastography come in the form of supersonic shear imaging 
(SSI) produced by Supersonic Imagine (France), which also relies on an acoustic radiation 
force to excite the shear wave. The resultant tissue elasticity information is provided in the 
form of an elasticity map which is overlaid on the B-mode image, rather than a numerical 
estimation of the shear wave velocity averaged across an interrogated area of interest. The SSI 
technique derives its elasticity map by relating tissue stiffness to the shear wave velocity, and, 
in the case of liver assessment, has also been shown to offer a quantitative assessment of liver 
parenchyma stiffness, where the global elasticity can be calculated from the measured 
image.17 The clinical application areas for the SSI technique also extend beyond the liver to 
encompass breast, prostate and thyroid imaging. SSI can be used to investigate relative 
elasticity in tissue and, thus, in these instances a suitable test object for this technique should 
contain lesion-like inserts of varying stiffness relative to the background TMM, with a range 
of mechanical properties similar to those found in the tissue of interest (see Table 2). Where 
SSI offers a quantitative estimation of a homogenous region of tissue, such as in the liver, a 
suitable phantom would be one which contained a set of homogenous regions of increasing 
stiffness for calibration of the systems’ ability to accurately determine the relevant tissue’s 
Young’s modulus.  
 
2.3 Transient Elastography 
Transient elastography utilises a low frequency short-pulsed excitation to excite the tissue of 
interest.6,9 The resultant mechanical stimulation causes the propagation of a low-frequency 
shear wave in the tissue with a velocity related to the tissue stiffness and which can be 
measured using an ultrasound pulse-echo mode.6,9 A current commercially-available 
implementation of transient elastography is the Fibroscan® system produced by Echosens 
(France). The Fibroscan® is designed for use in the assessment of liver fibrosis by 
quantifying liver stiffness, which has been shown to correlate with fibrosis, through the use of 
a shear elasticity probe. A shear wave, excited by a low-frequency vibrator with an ultrasonic 
single-element transducer, is tracked and its velocity derived. The system assumes that the 
liver is a uniform medium and consequently averages its single measurement over a specific 
region within the patient, and hence an appropriate phantom for assessment of this system’s 
accuracy would need to be homogenous rather than containing small targets as would 
typically be the case for a spatially-resolved technique.  
 
3. Relevant Standards and Design Criteria   
Ultrasound phantoms play an important role in the quality control (QC) and performance 
testing of ultrasound equipment, and are also very useful tools for providing an initial safe 
means for clinical training in instances where the phantom has clinically-relevant targets. In 
order to ensure that the measurements taken on such QC test phantoms are consistent with 
clinical performance, test objects should be tissue-mimicking, exhibiting similar acoustic 
properties to tissue across the range of frequencies used diagnostically.18 The “International 
Electrotechnical Commission (IEC) 1390” 19 and the “American Institute of Ultrasound in 
Medicine (AIUM) Standard 1990” 20 standards for conventional B-mode ultrasound tissue 
mimicking material recommend an acoustic velocity of 1540 m/s, attenuation coefficients of 
between 0.5 – 0.7 dBcm-1MHz-1 for the frequency range of 2 – 15 MHz, with a linear 
response of attenuation to frequency, f1, as detailed in Table 1. 
 
Table 1. Summary of the IEC 1390  and AIUM Standard 1990  standards for conventional B-
mode ultrasound tissue mimicking materials.19,20 
Acoustic Velocity 
(m/s)  
Attenuation 
Coefficient  
(dBcm-1MHz-1) 
Frequency Range 
(MHz) 
Response of 
Attenuation 
Coefficient to 
frequency  
1540 0.5 – 0.7 2 – 15 f1 (linear) 
 
However, for ultrasound elastography TMMs, no mechanical standards have been 
recommended. Nevertheless, it is reasonable to state that the IEC and AIUM standards should 
be applied for ultrasound elastography phantoms, with the additional integration into the 
design of the range of mechanical characteristics mimicking both healthy and pathological 
tissue. Indeed, the relevant commercial and scientific literature reveals that both 
manufacturers and researchers alike have designed ultrasound elastography TMMs to match 
the acoustic properties of soft tissue with some integration of the mechanical properties of 
soft tissue.21-37  Questions still remain, however, as to the efficacy and suitability of such 
TMMs for their intended purposes. Table 2 presents a list of suggested tissue mimicking 
properties matched to specific clinical applications, based on measured mechanical properties 
reported in a number of clinical studies.11,38-48 The background properties are usually 
representative of the approximate stiffness values of the healthy tissue in the respective 
clinical application, while the range of the target stiffness usually represents the typical values 
of malignant lesions. The minimum target dimensions seem to reflect the minimum lesion 
dimensions detected in the studies, while the elastic contrast is the ratio of the stiffness of the 
target to that of the background material. In the case of fibrosis of the liver, the liver 
parenchyma range represents those stiffness values encountered for the various stages of 
fibrosis of the liver, where the disease is regarded as affecting the whole liver rather than 
simply manifesting in the form of lesions. 
 
Table 2. Proposed mechanical properties for tissue mimicking materials, including 
background and target stiffness values and elastic contrast, in addition to the typical target 
dimensions for each of the respective clinical applications. 
Clinical 
Applications 
Mechanical Properties Typical Range 
of Target 
Dimensions 
(mm) 
Background 
(kPa) Target (kPa) 
Elastic 
Contrast 
Breast 11,38,39 25 30 – 200 1.2 – 8 1 – 20 
Prostate 40-43 15 10 – 40 0.7 – 2.7 5 – 40 
Thyroid 44,45 10 15 – 180 1.5 – 18 10 – 40 
Liver 46,47 3 3 – 16 1 – 5.3 10 – 80 
Liver parenchyma 48 3 – 30 – – – 
 
In Section 4, the current commercially-available ultrasound elastography test phantoms are 
described, with a distinction made between those aimed at QC testing and those developed 
primarily for training purposes. The properties of the phantoms are examined in the context of 
their tissue-mimicking characteristics and their suitability for their intended applications. An 
overview is then provided in Section 5 of the broad range of research phantoms which have 
been described in the literature, together with a description of the novel TMMs used in their 
construction. These TMMs, which were developed to optimally replicate both the acoustic 
and mechanical properties of the soft tissue of interest in the respective studies, will also be 
discussed in terms of the suitability of their application to the different ultrasound 
elastography techniques. 
 
4. Commercially-available elastography phantoms 
Only one company (Computerized Imaging Reference Systems CIRS) Inc., USA) has 
produced phantoms specifically designed for quality control testing and/or performance 
assessment of clinical ultrasound elastography systems. These phantoms (specifically models 
049 and 049a) contain targets of varying Young’s modulus values (quoted as being 8, 14, 45, 
80 kPa) embedded in a uniform background material with a stated Young’s modulus of 25 
kPa.23 The former contains spherical targets of diameter 10 and 20 mm while the latter 
contains a set of cylindrical target masses with varying diameters in the range 1.58 – 6.49 
mm. CIRS also produce a multi-purpose multi-tissue phantom (model 040GSE) with two sets 
of elastography targets (quoted as being 10, 40 and 60kPa) given below.24All elastography 
phantoms produced by CIRS are manufactured with the tissue-mimicking material Zerdine®, 
which has an acoustic velocity of approximately 1540 ± 10 m/s and an attenuation coefficient 
of 0.5 dB/cm/MHz,18 although the material’s response to frequency has been found to be non-
linear varying as 0.48f1.3.18 The embedded spherical and cylindrical targets are at clinically-
relevant depths for small parts applications, ranging from 15 – 60 mm in both the 049 and 
049a phantoms and 15 and 50 mm in the CIRS 040GSE.23,24 The Young’s modulus values, 
however, are of a limited range for determining the elastographic accuracy and across the full 
range encountered during clinical scanning of the prostate, breast and liver, and further do not 
adequately reflect the lesion-to-background elasticity ratio observed clinically. Furthermore, 
while the background material has a suitable Young’s modulus for mimicking breast tissue, 
the value is not appropriate in the case of the prostate, thyroid or liver. In addition, these 
phantoms are not suitable for the performance testing of devices such as the Fibroscan®, the 
operation of which dictates the use of a range of homogenous phantoms of varying Young’s 
modulus values rather than those containing embedded targets for the measurement of the 
stiffness of targets relative to the background tissue. Nevertheless, the designs of the CIRS 
phantoms are quite well suited to QC testing of small parts applications for static, ARFI and 
SSI elastography techniques. 
 
Clinical training phantoms, which are important for providing an initial safe tissue mimicking 
medium for clinical training purposes, are generally anthropomorphic in design, and 
commercially available from two manufacturers, namely CIRS Inc and Blue Phantom (USA). 
21,22,25 CIRS have produced two training phantoms, one for prostate scanning (model 066) and 
one for breast scanning (model 059). The CIRS model 066 phantom simulates the prostate 
area and adjoining structures and includes three randomly embedded 10mm diameter 
isoechoic lesions which are three times the stiffness of the simulated prostate tissue, thereby 
making the lesions detectable only when using elastographic techniques.22 There is, however, 
limited detail in both the commercial and scientific literature as to the stiffness values of both 
the background and target material of this phantom and whether they are representative of 
those seen clinically in the prostate. In addition, both the lesion diameter and elastic contrast 
are at the upper range of those reported clinically and thus may not be challenging enough to 
provide adequate training to the clinician or to adequately challenge the elastography 
technique under evaluation. The CIRS model 059 phantom mimics the anatomical and 
ultrasonic properties of breast tissue and similarly contains lesion-mimicking masses (2 – 10 
mm in diameter) of an isoechoic nature with a Young’s modulus, again, three times that of the 
background material.21 However, as with the model 066 phantom, there is limited information 
regarding the reported stiffness values of this phantom and furthermore, the target-to-
background ratio may not be challenging enough to provide adequate training to the clinician 
or to adequately challenge the evaluated elastography technique. The elastography phantom 
manufactured by Blue PhantomTM  is designed for breast applications and caters not only for 
elastography clinical training, having embedded lesions of varying stiffness and size, but also 
contains masses of varying echogenicity and varying diameter (6 – 11 mm) which can be used 
for conventional B-mode ultrasound training.25 However, once again, limited details of the 
stiffness values of both the target and background material, or indeed of the elastic contrast, 
have been reported in either the commercial and scientific literature and thus, it is difficult to 
ascertain the capabilities of this phantom in terms of its ability to fully mimic the properties of 
breast tissue.  
 
The clinical training phantoms described above have been developed specifically for imaging 
and biopsy training purposes in the clinical applications of breast and prostate imaging. 
Nevertheless, it is clear that considerable further scope exists for the development of more 
clinically-relevant phantoms for both QC/performance testing and training purposes, from the 
point of view of replicating a broader range of pathologies in the areas currently mimicked 
but also for extending the application to other anatomical sites of interest.  
 
5.  Research elastography phantoms 
A wide variety of phantoms developed by elastography research laboratories have been 
reported in the literature, where the motivation has typically been to evaluate the performance 
of the ever-increasing range of research and commercial ultrasound elastography techniques. 
Many of these groups have focused on the use of novel TMMs in the construction of these 
phantoms, with a view to extending the range of pathologies and/or anatomical sites to which 
they can be applied, extending their reach beyond that of the commercially-available 
phantoms. Thus, these phantoms will be reviewed in the following sub-sections by 
categorising them according to the TMM used in their construction. Table 3 lists details of 
both the research and commercial phantoms including their acoustic and mechanical 
properties and their limitations.    
 
5.1 Agar and gelatine dispersions 
The combination of agar and gelatin in TMMs has revealed interesting characteristics, with 
the ultimate stiffness properties of the material controllable with the addition of macroscopic 
safflower oil droplets, and the acoustic velocity and attenuation controlled by the addition of 
propylene glycol and glass beads, respectively. TMMs based on these constituent materials 
have been used to produce relatively simple heterogeneous phantoms containing inserts of 
varying elastic contrast, with the geometry and elastic properties of the material proving to be 
relatively stable with time.26 Further development of the material as an elastography tissue-
mimic has seen it utilised in the manufacture of an anthropomorphic breast phantom, 
mimicking the properties of both subcutaneous fat and glandular tissue. In addition, 
embedded lesion-like inserts with a variety of geometries and mechanical properties have 
been constructed, representing a range of pathologies.27,28 The Young’s modulus values 
produced by these agar and gelatin dispersions have ranged between 5 – 135 kPa, a range 
representative of soft tissue, while the acoustic velocity and attenuation values achieved have 
ranged between 1492 – 1575 m/s and 0.1 – 0.52 dB/cm/MHz, respectively, again 
representative of soft tissue.26-28 Agar and gelatin based materials have proved successful in 
validating and testing transient elastography using acoustic radiation force impulse ,30 where 
the produced phantom has contained targets of high stiffness embedded in a lower Young’s 
modulus background material. Another clinical application of this TMM has been the carotid 
artery, where the mechanical properties of the carotid artery were successfully mimicked for 
validation of noninvasive strain imaging using gelatin dispersions.29 It is clear that the agar 
and gelatine dispersions can demonstrate great versatility across clinical applications and can 
be used in phantoms for any of the elastography techniques; however, the full potential of this 
TMM has yet to be explored. Furthermore, the proposed function of agar and gelatin 
dispersion phantoms has been to serve as intermediaries between simple phantoms and actual 
patients in order to assess elastography systems and techniques in the research stage,27 and 
thus, little emphasis has been placed on producing phantoms suitable for QC of 
commercially-available systems. In addition, the manufacture process of such dispersions 
involves the use of formaldehyde, a highly toxic chemical, which may discourage production 
of the TMM in a hospital environment where the necessary fume hood and production 
equipment may not be available.   
 
5.2 Copolymer-in-oil 
A relatively novel approach to the manufacture of phantoms for transient elastography 
systems has seen the emergence of compounds based on the principal ingredient styrene-
ethylene/butylene-tyrene (SEBS)–type copolymers. These copolymers are mixed with mineral 
oil and acoustic scatterers, and processed to form a soft elastic translucent media of 
controllable mechanical properties. With an increase in the SEBS copolymer concentration in 
the mixture, an exponential increase in the Young’s modulus of the material is produced. The 
material has been shown to be stable over time and to exhibit the mechanical properties of a 
number of different types of soft tissue.31 A Young’s modulus range from 2.2 – 150 kPa has 
been achieved while the attenuation coefficient has been shown to range from 0.4 – 4.0 
dB/cm. Although such results have proved encouraging, the acoustic velocity range of 1420 – 
1464 m/s is much lower than that prescribed by the IEC and AIUM standards.19,20 Similarly, 
the density of the material has been found to be 0.90 ± 0.04 g/cm3, a figure that is 
significantly less than that expected of soft tissue.31 While the achievable acoustic velocities 
are much less than that of soft tissue, the attainable Young’s moduli of this material may 
prove to be useful for assessing transient elastographic techniques where a homogenous test 
object is needed, indicating its potential for evaluating the performance of elastography 
systems. This TMM, however, has not been used to construct phantoms which contain targets 
of varying stiffness relative to background material, and hence it may not be suitable for static 
elastography or ARFI where this design of phantom is necessary for QC testing.  
 
5.3 Poly(vinyl) Alcohol Cryogel (PVA-C) 
Poly(vinyl) alcohol-cryogel, a relatively novel TMM, is manufactured through repeated 24 hr 
freeze-thaw cycling (-20°C and +20°C) of aqueous high-grade PVA solution, which produces 
a gelation effect. Cross-linking occurs when crystal nuclei are generated in the freezing stage, 
and, on thawing, these nuclei grow into crystallites that act as cross-linking sites for the 
polymer.7,32-34 Variation of the initial PVA-C concentration, the thawing rates and the number 
of freeze/thaw cycles have been identified as a means of manipulating the material’s Young’s 
modulus, making it possible to produce samples with a range of 2 – 600 kPa, which covers 
both healthy and pathological tissue.32,35 In addition, the acoustic velocity and attenuation 
coefficient of PVA-C can be altered by varying the glycerol content and the scatterer content 
respectively, producing tissue-mimicking ranges of 1505 – 1570 m/s and 0.2 – 0.6 
dB/cm/MHz, respectively.35 A further advantageous feature of this material is its 
compatibility to both magnetic resonance and ultrasound imaging, and thus, it has been used  
Phantom/ 
Material 
Commercial
/Research 
Purpose/ 
Application 
Acoustic Properties Mechanical Properties 
Range of 
Target 
Dimensions 
(mm) 
Limitations/ Disadvantages Acoustic 
Velocity (m/s) 
Attenuation 
Coefficient 
(dBcm-
1MHz-1) 
Targets 
(kPa) 
Background 
(kPa) 
Elastic 
Contrast 
CIRS 05921   Commercial 
Anatomical training 
phantom for breast 
elastography and biopsy 
1540 ± 10 0.5 n/a n/a 3 2 – 10 
Elastic contrast very high. 
Limited detail of mechanical 
properties. 
CIRS 06622   Commercial 
Anatomical training 
phantom for prostate 
elastography and biopsy 
1540 ± 10 0.5 n/a n/a 3 10 
Elastic contrast very high. 
Limited detail of mechanical 
properties. Target dimensions 
large 
Blue 
Phantom25   Commercial 
Anatomical training 
phantom for breast 
elastography and biopsy 
n/a n/a n/a n/a n/a 6 – 11 
Limited detail of mechanical and 
acoustic properties. Target 
dimensions large for breast. 
CIRS 049 & 
049a23 
Commercial Elasticity phantoms for 
QA 1540 ± 10 
0.5 8, 14, 45, 80 25 0.3 – 3 1.58 – 6.49 
Background mechanical 
properties suitable for breast 
only. 
CIRS 
040GSE24   
Commercial Multi-purpose multi-
tissue phantoms for QA 1540 ± 10 
0.5 & 0.7 10, 40, 60 n/a n/a 6 – 8 
Limited detail of background 
mechanical properties. Limited 
number of targets. 
Agar and 
gelatine26-30   Research 
Anthropomorphic breast, 
carotid phantoms for 
testing transient and ARFI 
elastography 
1492 – 1575 0.1 – 0.52 15 – 92 5 – 135 0.5 – 4.6 0.5 – 14 
Manufacture process involves 
toxic chemicals. 
Copolymer-
in-oil31   Research 
Transient elastography 
accuracy measurement 1420 – 1464 0.4 – 4.0 n/a 2.2 – 150 n/a n/a 
Has not been used to construct 
embedded targets thus not 
applicable to ARFI and Static 
elastography. Acoustic velocity 
low 
Poly(vinyl 
alcohol) 
cryogel32-37   
Research 
Transient elastography 
accuracy measurement, 
multi-modality studies 
1505 – 1570 0.2 – 0.6 n/a 4 – 615 n/a n/a 
Has not been used to construct 
embedded targets thus not 
applicable to ARFI and static 
elastography. 
to construct a range of tissue mimicking phantoms for QC testing and research for both 
ultrasound and MR imaging.33,34,36 The accuracy of a commercially-available reflective-mode 
transient elastography system has been assessed using PVA-C as a test object to mimic the 
shear elastic, acoustic velocity and attenuation coefficient characteristics of the progressive 
states of liver fibrosis.35 Furthermore,intravascular studies have employed PVA-C to simulate 
the local elastic properties of plaque and of the surrounding carotid arterial wall and similarly 
the material has been used in the construction of aortic vessel phantoms, proving the material 
to be durable and replicative of the vessel wall stiffness.7,33 Anatomically-realistic renal artery 
vessels has also been mimicked in terms of both their acoustic and mechanical properties.37 
Anthropomorphic brain phantoms, multi-volume stenosed vessel phantoms and breast biopsy 
phantoms have also been successfully developed using PVA-C as the base TMM for multi-
modality studies.34 Although PVA-C has been useful not only for research purposes but also 
in the assessment of commercial clinical elastography systems, the material must be 
processed under very specific conditions in order to achieve specific stiffness values, and thus 
the TMM can be laborious to manufacture. Similarly, as is the case for copolymer-in-oil 
TMM, PVA-C has not been used to construct targets of elevated stiffness relative to the 
background phantom material, and thus has not yet been proven appropriate for QC testing of 
static elastography and ARFI. 
 
6. Conclusion 
There is a continued strong interest in the growing clinical utilisation of elastographic 
techniques for  both qualitatively visualising and quantitatively measuring the mechanical 
properties of soft tissues, presenting new clinical information relating to the pathological state 
of tissue as an adjunct to conventional ultrasound imaging techniques.49 It is vitally important 
that these new techniques are fully evaluated technically as well as clinically before they are 
introduced into routine clinical practice. Furthermore, as with all ultrasound techniques, there 
is a requirement for clinicians and sonographers to be adequately trained to enable them to 
acquire high quality images, free from artefacts and, further, for them to understand the role 
of instrument controls on the resultant image quality. Accordingly, TMM phantoms have a 
valuable role to play and there is thus an equal requirement for commercial availability of 
suitable tissue mimicking anthropomorphic phantoms. Despite the relatively large number of 
phantoms reviewed here which are either commercially-available or under development in 
various research laboratories, few of these phantoms adequately meet the requirements of the 
different ultrasound elastography techniques or the range of clinical applications in terms of 
their mechanical properties and the characteristics of their test targets. There thus exists a 
clear need for the continued development of suitable tissue mimicking phantoms with more 
specialised designs, moving away from the current general purpose phantom approach used 
by some manufacturers to more anatomically-specific phantom designs. The rapid pace of 
developments of elastographic systems will likely continue over the coming years, which will 
further challenge our ability to adequately assess the performance of these diagnostic systems 
and train staff in their use. 
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